Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Erella Livne
Introduction
Erella Livne is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of biomedical engineering, particularly in the development of advanced scaffolding techniques for tissue regeneration. With a total of 2 patents to her name, her work is paving the way for innovative medical solutions.
Latest Patents
Erella Livne's latest patents include groundbreaking technologies such as "Electrospun scaffolds and methods of generating and using same." This patent discloses a porous scaffold comprising electrospun polymeric nanofibers, with an average pore diameter of about 300 µm. The polymeric nanofibers have an average diameter ranging from about 100 to 400 nm. The scaffold may also include a plurality of particles greater than about 1 µm in diameter. Additionally, methods for fabricating scaffolds and using them for tissue reconstruction are detailed in this patent. Another notable patent is "Medical scaffold, methods of fabrication and using thereof," which provides articles of manufacturing that include electrospun elements with gradients of porosity and agents for promoting cell colonization and migration. These innovations are crucial for guiding tissue regeneration.
Career Highlights
Erella Livne is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving medical technologies and enhancing patient outcomes through innovative solutions.
Collaborations
Erella has collaborated with notable colleagues such as Samer Srouji and Eyal Zussman, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Erella Livne's contributions to the field of biomedical engineering through her patents and collaborative efforts highlight her role as a leading inventor. Her work in developing advanced scaffolding techniques is set to make a lasting impact on tissue regeneration and medical technology.